![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSELOl8dC2lmIvKl34wceS1g8GuoN1XKgT5Vbu5pBt2_uwwbQ8Qaqlj6tCmhL6IVfZl2xO5ZiwuFsp8RBsQnclJGlfCEMkMMYWUGZ76u2oAh9sy5TJYgdxd-Ow1KnAojTMdhE8SIdSH77w/s320/domainnamelogo.jpg)
Withdrawals of Application - Medicinal Products for Human Use
Oncophage [Vitespen]
Withdrawal EPAR
The European Medicines Agency has been formally notified by Antigenics Therapeutics Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine Oncophage (vitespen), 20 μg solution for infusion.
abrir aquí para acceder al documento EMEA completo:
European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Oncophage
file3848month480
No hay comentarios:
Publicar un comentario